PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MIT researchers discover an unexpected twist in cancer metabolism

Cancer-cell quirk could be exploited to develop new drugs that starve tumors

2010-09-16
(Press-News.org) CAMBRIDGE, Mass. -- In a paper appearing in the Sept. 16 online edition of Science, Matthew Vander Heiden assistant professor of biology and member of the David H. Koch Institute for Integrative Cancer Research at MIT and researchers at Harvard University report a previously unknown element of cancer cells' peculiar metabolism. They found that cells can trigger an alternative biochemical pathway that speeds up their metabolism and diverts the byproducts to construct new cells.

The finding could help scientists design drugs that block cancer-cell metabolism, essentially starving them of the materials they need to grow and spread. Vander Heiden has just begun tests in mice of several such drugs.

Just as trees can be turned into logs to build a new house, or firewood to generate heat, sugar can serve many purposes. In a normal cell, most of the sugar is burned up for energy, with little left over to build anything new. Cancer cells, on the other hand, need building blocks for new cells as well as energy.

"If you have a forest of trees, you can take all the trees and burn them and release a lot of energy, but you haven't built anything," says Vander Heiden. "To build a house out of it, you need to save some logs to turn them into lumber."

Most human cells burn a six-carbon sugar called glucose. Through a long chain of reactions that require oxygen, the cells extract energy from the sugar and store it in molecular energy packets known as ATP. Cells use ATP to power a variety of functions, such as transporting molecules in and out of the cell, contracting muscle fibers and maintaining cell structure.

Glucose metabolism normally occurs in two stages, the first of which is known as glycolysis. It has been known for decades that cancer cells perform gylcolysis only, skipping the second stage, which is where most of the ATP is generated.

Vander Heiden's new study focuses on glycolysis, traditionally thought to be a linear, nine-step process by which a cell turns one molecule of glucose into two molecules of pyruvate, an organic compound with three carbon atoms. That pyruvate is usually fed into the second phase of glucose metabolism.

"Everyone takes it for granted that this is how it works," says Vander Heiden, who did this research as a postdoctoral fellow in the lab of Harvard Medical School Professor Lewis Cantley, senior author of the paper. But the new study shows that "there is another way it can work, and this other way seems to be at play in proliferating cells." That could include rapidly dividing embryonic cells as well as cancer cells.

Scientists already knew that cancer cells replace one type of a key metabolic enzyme known as pyruvate kinase with another. Both versions of the enzyme (PKM1 and PKM2) catalyze the very last step of glycolysis, which is the transformation of a compound called PEP to the final product, pyruvate.

In the new study, the researchers found that PEP is involved in a previously unknown feedback loop that bypasses the final step of glycolysis. In cancer cells, PKM2 is not very active, causing PEP to accumulate. That excess PEP activates an enzyme called PGAM, which catalyzes an earlier step in glycolysis. When PGAM receives that extra boost, it produces even more PEP, creating a positive feedback loop in which the more PEP a cell has, the more it makes.

The most important result of this loop is that the cell generates a large pool of another chemical that is formed during an intermediate step of the reaction chain. Vander Heiden believes this compound, called 3-phosphoglycerate, is diverted into synthetic pathways such as the production of DNA, which can become part of a new cancer cell. In future studies, he plans to investigate how that diversion occurs.

This study suggests that drugs that activate PKM2 could be promising cancer treatments, says Vander Heiden. If PKM2 were highly activated, cancer cells would alter the metabolism of PEP, blocking the alternative pathway and hindering the production of new building blocks.

###

Funding: Damon Runyon Cancer Research Foundation, the Burroughs Wellcome Fund, the American Cancer Society and the National Institutes of Health

Source: "Evidence for An alternative glycolytic Pathway in rapidly proliferating cells." Matthew G. Vander Heiden, Jason W. Locasale D. Swanson, Hadar Sharfi, Greg J. Heffron, Daniel Amador-Noguez, Heather R. Christofk, Gerhard Wagner, Joshua D. Rabinowitz, John M. Asara, and Lewis C. Cantley. Science, 17 September, 2010.

END



ELSE PRESS RELEASES FROM THIS DATE:

Foraging for fat: Crafty crows use tools to fish for nutritious morsels

Foraging for fat: Crafty crows use tools to fish for nutritious morsels
2010-09-16
Tool use is so rare in the animal kingdom that it was once believed to be a uniquely human trait. While it is now known that some non-human animal species can use tools for foraging, the rarity of this behaviour remains a puzzle. It is generally assumed that tool use played a key role in human evolution, so understanding this behaviour's ecological context, and its evolutionary roots, is of major scientific interest. A project led by researchers from the Universities of Oxford and Exeter examined the ecological significance of tool use in New Caledonian crows, a species ...

Optimizing climate change reduction

Optimizing climate change reduction
2010-09-16
Palo Alto, CA—Scientists at the Carnegie Institution's Department of Global Ecology have taken a new approach on examining a proposal to fix the warming planet. So-called geoengineering ideas—large-scale projects to change the Earth's climate—have included erecting giant mirrors in space to reflect solar radiation, injecting aerosols of sulfate into the stratosphere making a global sunshade, and much more. Past modeling of the sulfate idea looked at how the stratospheric aerosols might affect Earth's climate and chemistry. The Carnegie researchers started out differently ...

Imbalanced diet and inadequate exercise may underlie asthma in children

2010-09-16
Even children of a healthy weight who have an imbalanced metabolism due to poor diet or exercise may be at increased risk of asthma, according to new research, which challenges the widespread assumption that obesity itself is a risk factor for asthma. "Our research showed that early abnormalities in lipid and/or glucose metabolism may be associated to the development of asthma in childhood," said lead author Giovanni Piedimonte, M.D., who is professor and chairman of the Department of Pediatrics at West Virginia University School of Medicine, physician-in-chief at WVU ...

Tulane University researchers find ancient roots for SIV

2010-09-16
VIDEO: The following video relates to a Science paper featuring contributing author Preston Marx, a Tulane University virologist. The article, "Island Biogeography Reveals the Deep History of SIV, " is embargoed until... Click here for more information. The HIV-like virus that infects monkeys is thousands of years older than previously thought, according to a new study led by researchers from Tulane University. Simian immunodeficiency virus (SIV), which is the ...

Alzheimer's drug boosts perceptual learning in healthy adults

2010-09-16
Berkeley — Research on a drug commonly prescribed to Alzheimer's disease patients is helping neuroscientists at the University of California, Berkeley, better understand perceptual learning in healthy adults. In a new study, to be published online Thursday, Sept. 16, in the journal Current Biology, researchers from UC Berkeley's Helen Wills Neuroscience Institute and School of Optometry found that study participants showed significantly greater benefits from practice on a task that involved discriminating directions of motion after they took donepezil, sold under the ...

How does Prozac act? By acting on the microRNA

2010-09-16
The response time to antidepressants, such as Prozac, is around three weeks. How can we explain this? The adaptation mechanisms of the neurons to antidepressants has, until now, remained enigmatic. Research, published this week by the teams of Odile Kellermann (Inserm Unit 747 Cellules souches, Signalisation et Prions, Université Paris-Descartes) and of Jean-Marie Launay (Inserm Unit 942 Hôpital Lariboisière, Paris and the mental health network, Santé Mentale), sheds new light on the mechanisms of action of these drugs which have been used for more than 30 years and are ...

Toward resolving Darwin's 'abominable mystery'

Toward resolving Darwins abominable mystery
2010-09-16
What, in nature, drives the incredible diversity of flowers? This question has sparked debate since Darwin described flower diversification as an 'abominable mystery.' The answer has become a lot clearer, according to scientists at the University of Calgary whose research on the subject is published today in the on-line edition of the journal Ecology Letters. Drs. Jana Vamosi and Steven Vamosi of the Department of Biological Sciences have found through extensive statistical analysis that the size of the geographical area is the most important factor when it comes to biodiversity ...

AIDS virus lineage much older than previously thought

AIDS virus lineage much older than previously thought
2010-09-16
An ancestor of HIV that infects monkeys is thousands of years older than previously thought, suggesting that HIV, which causes AIDS, is not likely to stop killing humans anytime soon, finds a study by University of Arizona and Tulane University researchers. The simian immunodeficiency virus, or SIV, is at least 32,000 to 75,000 years old, and likely much older, according to a genetic analysis of unique SIV strains found in monkeys on Bioko Island, a former peninsula that separated from mainland Africa after the Ice Age more than 10,000 years ago. The research, which appears ...

Scientists report new insights into the moon's rich geologic complexity

2010-09-16
The moon is more geologically complex than previously thought, scientists report Sept. 17 in two papers published in the journal Science. Their conclusion is based on data from the Diviner Lunar Radiometer Experiment aboard NASA's Lunar Reconnaissance Orbiter (LRO), an unmanned mission to comprehensively map the entire moon. The spacecraft orbits some 31 miles above the moon's surface. The new data reveal previously unseen compositional differences in the moon's crustal highlands and have confirmed the presence of material surprisingly abundant in silica — a compound ...

Mediterranean countries offer fewer urban transport options than Central European ones

Mediterranean countries offer fewer urban transport options than Central European ones
2010-09-16
Catalan researchers have studied the factors relating to urban transport service provision in 45 European cities, including Barcelona, Bilbao and Madrid. The study, published in the latest issue of Transportation research part E-logistics and transportation review, concludes that Central European cities have the best urban transport service provision in Europe. Capital cities are at the head of the league, both in terms of supply and demand. "The geographic variables we studied show that Mediterranean countries have the least developed (offer the poorest range) in terms ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] MIT researchers discover an unexpected twist in cancer metabolism
Cancer-cell quirk could be exploited to develop new drugs that starve tumors